NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against agilon health, inc. (NYSE: AGL), DocGo, Inc. (NASDAQ: DCGO), and Endeavour Mining plc (OTC: EDVMF). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
agilon health, inc. (NYSE: AGL)
On January 5, 2024, Agilon Health announced revised guidance expectations for 2023 and stated that "[d]uring 2023, agilon health experienced an increase in medical expenses attributable to higher-than-expected specialist visits, Part B drugs, outpatient surgeries, and supplemental benefits, partially offset by lower hospital medical admissions." In a separate press release, Agilon Health "announced that Timothy Bensley has informed the company of his intent to retire from his position as Chief Financial Officer (CFO) during 2024, which agilon expects to take place within the next nine months."
On this news, Agilon Health's stock price fell $3.45 per share, or 28.56%, to close at $8.63 per share on January 5, 2024.
For more information on the agilon health investigation go to: https://bespc.com/cases/AGL
DocGo, Inc. (NASDAQ: DCGO)
On January 10, 2024, before the market opened, Fuzzy Panda Research released a report entitled “DocGo – Allegations of Fraudulent Billing Practices & Forging of Documents.” Fuzzy Panda further stated that “through former employee interviews and never before seen lawsuits we discovered serious allegations that DocGo (DCGO) has allegedly been committing Medicare fraud and having employees forge signatures on medical documents.”
On this news, the price of DocGo stock fell sharply in intraday trading on January 10, 2024.
For more information on the DocGo investigation go to: https://bespc.com/cases/DCGO
Endeavour Mining plc (OTC: EDVMF)
On January 4, 2024, Endeavour’s Board of Directors announced the termination of Endeavour’s President and Chief Executive Officer (“CEO”), Sebastien de Montessus, following the Board’s investigation “into an irregular payment instruction issued by him in relation to an asset disposal.” The Board stated that it had become aware of a $5.9 million payment instruction in connection with a review of acquisitions and disposals and that de Montessus had been terminated for serious misconduct with “immediate effect.”
On this news, Endeavour’s stock price fell $2.20 per share, or 10.14%, to close at $19.50 per share on January 4, 2024.
For more information on the Endeavour investigation go to: https://bespc.com/cases/EDVMF
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com
